From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023)
This review employs bibliometric methods to map the evolving landscape of prostate cancer endocrine therapy research over the past 15 years. Through analysis of 961 articles from the Web of Science Core Collection, we identified key trends in therapeutic innovation and clinical translation. The Unit...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-06-01
|
| Series: | American Journal of Men's Health |
| Online Access: | https://doi.org/10.1177/15579883251346819 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850208822703947776 |
|---|---|
| author | Longjun Huang Wenjuan He Yong Guo |
| author_facet | Longjun Huang Wenjuan He Yong Guo |
| author_sort | Longjun Huang |
| collection | DOAJ |
| description | This review employs bibliometric methods to map the evolving landscape of prostate cancer endocrine therapy research over the past 15 years. Through analysis of 961 articles from the Web of Science Core Collection, we identified key trends in therapeutic innovation and clinical translation. The United States emerged as the dominant contributor (34.96% of publications), with Harvard University and the University of California System leading institutional output. Three paradigm shifts emerged: early stage research focused on optimizing androgen deprivation therapy (ADT) efficacy (2008–2013), followed by castration-resistant prostate cancer (CRPC) drug development (2014–2016), and recent emphasis on combination therapies and molecular targeting (2017–2023). The top 50 most cited papers confirmed that keyword clusters directly corresponded to pivotal trials, including TAMPEDE (NCT00268476) and PROSPER (NCT02003924). The translational science spectrum model revealed that 68% of current clinical applications originated from basic research on androgen receptor variants. Emerging frontiers include prostate-specific membrane antigen-targeted radioligand therapy and immunotherapy-ADT synergies. This synthesis provides clinicians with an evidence-based roadmap to navigate therapeutic advancements while highlighting the critical need for international collaboration in addressing persistent challenges such as treatment resistance. |
| format | Article |
| id | doaj-art-5773bfbe39734ad1bb63f46cb97f5afb |
| institution | OA Journals |
| issn | 1557-9891 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | American Journal of Men's Health |
| spelling | doaj-art-5773bfbe39734ad1bb63f46cb97f5afb2025-08-20T02:10:09ZengSAGE PublishingAmerican Journal of Men's Health1557-98912025-06-011910.1177/15579883251346819From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023)Longjun Huang0Wenjuan He1Yong Guo2The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaThe First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, ChinaDepartment of Oncology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, ChinaThis review employs bibliometric methods to map the evolving landscape of prostate cancer endocrine therapy research over the past 15 years. Through analysis of 961 articles from the Web of Science Core Collection, we identified key trends in therapeutic innovation and clinical translation. The United States emerged as the dominant contributor (34.96% of publications), with Harvard University and the University of California System leading institutional output. Three paradigm shifts emerged: early stage research focused on optimizing androgen deprivation therapy (ADT) efficacy (2008–2013), followed by castration-resistant prostate cancer (CRPC) drug development (2014–2016), and recent emphasis on combination therapies and molecular targeting (2017–2023). The top 50 most cited papers confirmed that keyword clusters directly corresponded to pivotal trials, including TAMPEDE (NCT00268476) and PROSPER (NCT02003924). The translational science spectrum model revealed that 68% of current clinical applications originated from basic research on androgen receptor variants. Emerging frontiers include prostate-specific membrane antigen-targeted radioligand therapy and immunotherapy-ADT synergies. This synthesis provides clinicians with an evidence-based roadmap to navigate therapeutic advancements while highlighting the critical need for international collaboration in addressing persistent challenges such as treatment resistance.https://doi.org/10.1177/15579883251346819 |
| spellingShingle | Longjun Huang Wenjuan He Yong Guo From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) American Journal of Men's Health |
| title | From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) |
| title_full | From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) |
| title_fullStr | From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) |
| title_full_unstemmed | From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) |
| title_short | From Androgen Deprivation to Precision Therapy: A Bibliometric Review of Global Research Trends (2008–2023) |
| title_sort | from androgen deprivation to precision therapy a bibliometric review of global research trends 2008 2023 |
| url | https://doi.org/10.1177/15579883251346819 |
| work_keys_str_mv | AT longjunhuang fromandrogendeprivationtoprecisiontherapyabibliometricreviewofglobalresearchtrends20082023 AT wenjuanhe fromandrogendeprivationtoprecisiontherapyabibliometricreviewofglobalresearchtrends20082023 AT yongguo fromandrogendeprivationtoprecisiontherapyabibliometricreviewofglobalresearchtrends20082023 |